0001181431-12-011053.txt : 20120223 0001181431-12-011053.hdr.sgml : 20120223 20120223122219 ACCESSION NUMBER: 0001181431-12-011053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120214 FILED AS OF DATE: 20120223 DATE AS OF CHANGE: 20120223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YACHMETZ PHILIP K CENTRAL INDEX KEY: 0001250318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12632799 MAIL ADDRESS: STREET 1: 501 LAFAYETTE AVE CITY: WYCKOFF STATE: NJ ZIP: 07481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd335615.xml X0304 4 2012-02-14 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001250318 YACHMETZ PHILIP K SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, General Counsel Common Stock, $.01 par value per share 2012-02-14 4 S 0 3540 2.02 D 235484 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 13, 2009 /s/ Irina Ishak for Philip Yachmetz 2012-02-23